The Manufacturers Life Insurance Company Purchases New Holdings in Sotera Health Company $SHC

The Manufacturers Life Insurance Company acquired a new position in shares of Sotera Health Company (NASDAQ:SHC) during the 2nd quarter, Holdings Channel.com reports. The fund acquired 190,197 shares of the company’s stock, valued at approximately $3,376,000.

Other hedge funds have also bought and sold shares of the company. BlackRock Inc. purchased a new stake in Sotera Health in the second quarter worth about $428,635,000. Sculptor Capital LP lifted its holdings in shares of Sotera Health by 3.4% during the first quarter. Sculptor Capital LP now owns 21,717,728 shares of the company’s stock valued at $311,432,000 after purchasing an additional 717,728 shares during the last quarter. Vanguard Group Inc. boosted its position in shares of Sotera Health by 16.7% in the 4th quarter. Vanguard Group Inc. now owns 19,228,375 shares of the company’s stock worth $339,189,000 after purchasing an additional 2,756,583 shares in the last quarter. Sachem Head Capital Management LP boosted its position in shares of Sotera Health by 47.2% in the 4th quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company’s stock worth $205,418,000 after purchasing an additional 3,735,000 shares in the last quarter. Finally, Janus Henderson Group PLC grew its stake in shares of Sotera Health by 35.3% in the 1st quarter. Janus Henderson Group PLC now owns 9,162,191 shares of the company’s stock worth $131,413,000 after buying an additional 2,390,132 shares during the last quarter. Institutional investors own 91.03% of the company’s stock.

Insider Transactions at Sotera Health

In other Sotera Health news, Chairman Michael B. Jr. Petras sold 850,000 shares of the business’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $18.50, for a total transaction of $15,725,000.00. Following the completion of the sale, the chairman directly owned 3,969,393 shares in the company, valued at $73,433,770.50. The trade was a 17.64% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Michael P. Rutz sold 150,000 shares of the company’s stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the sale, the insider directly owned 334,279 shares of the company’s stock, valued at $6,297,816.36. The trade was a 30.97% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 1,294,515 shares of company stock valued at $23,999,528. Corporate insiders own 15.36% of the company’s stock.

Wall Street Analyst Weigh In

SHC has been the subject of a number of analyst reports. JPMorgan Chase & Co. raised their price objective on Sotera Health from $16.00 to $18.00 and gave the company a “neutral” rating in a research report on Friday, August 7th. UBS Group set a $19.00 target price on Sotera Health in a research note on Wednesday, June 24th. Weiss Ratings upgraded Sotera Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Tuesday, August 11th. Citigroup lifted their price target on Sotera Health from $23.00 to $25.00 and gave the stock a “buy” rating in a research report on Friday, August 7th. Finally, Wall Street Zen upgraded shares of Sotera Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday. Eight research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $21.50.

Sotera Health Price Performance

NASDAQ SHC opened at $18.68 on Wednesday. The stock has a market capitalization of $5.33 billion, a price-to-earnings ratio of 32.77 and a beta of 1.77. Sotera Health Company has a 1-year low of $13.09 and a 1-year high of $19.85. The company has a debt-to-equity ratio of 3.33, a current ratio of 2.80 and a quick ratio of 2.55. The business’s fifty day moving average price is $18.24 and its 200-day moving average price is $16.42.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.26 EPS for the quarter, topping the consensus estimate of $0.24 by $0.02. The company had revenue of $321.38 million during the quarter, compared to analyst estimates of $309.70 million. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.Sotera Health’s revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.20 earnings per share. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. On average, equities analysts predict that Sotera Health Company will post 0.86 earnings per share for the current year.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.